Literature DB >> 6269560

Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat.

A E Kelley, L Stinus, S D Iversen.   

Abstract

We have investigated the interaction between opioid peptides and dopaminergic A10 (DA-A10) neurones in the ventral tegmental area (VTA). The behavioural consequences of VTA infusion of d-Ala-Met-enkephalinamide (DALA) were analyzed. DALA elicited a dose-dependent increase in locomotor activity measured in photocell cages and the circular corridor. Observations in the open field and in a hole box revealed that DALA-induced behavioural stimulation was characterized by enhancement of locomotion, rearing, and number of hole visits, while grooming time and duration of hole visits were decreased. DALA-induced stimulation was reserved by naloxone, and was completely blocked by 6-OHDA destruction of DA-A10 terminals. d-Amphetamine-induced behavioural activation was potentiated by simultaneous VTA infusion of DALA which indicates that the behavioural response to DALA is dependent on DA-A10 neuronal activity. It is postulated that stimulation of opiate receptors exerts a presynaptic inhibition of an inhibitory input to DA-A10 neurones (eg. GABA or dendritic DA), thus releasing dopaminergic activity. In contrast to the acute effect, the d-amphetamine response was strongly attenuated 4 h, 1 and 6 days after VTA infusion of DALA, and returned to normal only at 14 days. This long-lasting modification may reflect decreased activity of opioid neurones, releasing the inhibition of DA-A10 neurones. Our findings suggest that endogenous opioid peptides may exert a modulatory influence on the dopaminergic mesocorticolimbic system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6269560     DOI: 10.1016/0166-4328(80)90043-1

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  36 in total

1.  Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide.

Authors:  J L Neisewander; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.

Authors:  G Calenco-Choukroun; V Daugé; G Gacel; J Féger; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse.

Authors:  J L Rogers; S Ghee; R E See
Journal:  Neuroscience       Date:  2007-10-22       Impact factor: 3.590

Review 4.  New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system.

Authors:  Susan F Volman; Stephan Lammel; Elyssa B Margolis; Yunbok Kim; Jocelyn M Richard; Mitchell F Roitman; Mary Kay Lobo
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

5.  Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.

Authors:  V Daugé; P Rossignol; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 6.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

7.  Dopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse.

Authors:  Ronald E See
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-23       Impact factor: 5.176

8.  Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates.

Authors:  L Stinus; M Winnock; A E Kelley
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Opioid peptides and self-stimulation of the medial prefrontal cortex in the rat.

Authors:  S G Shaw; F Vives; F Mora
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Morphine withdrawal aggression: modification with D1 and D2 receptor agonists.

Authors:  J W Tidey; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.